JASON RITENOUR: Open Payments
NPI 1770167850 · VENICE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,078 in 51 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,078
Food & beverage: $1,078
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $153 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $138 |
| Lundbeck LLC | 5 | $127 |
| Axsome Therapeutics, Inc. | 5 | $110 |
| Vanda Pharmaceuticals Inc. | 3 | $78 |
| Alkermes, Inc. | 3 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Noven Therapeutics, LLC | 3 | $60 |
| Supernus Pharmaceuticals, Inc. | 3 | $52 |
| Janssen Pharmaceuticals, Inc | 2 | $51 |
Products named: REXULTI, VRAYLAR, CAPLYTA, Auvelity, FANAPT, ARISTADA, INVEGA SUSTENNA, Xelstrym.
Industry payments across FL — which companies pay providers there.
